Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNAPSE: Paracetamol and Nimotop for Postictal Symptoms after ECT
NCT04028596Phase 2Completed
- Sponsor
- Rijnstate
- Start
- Dec 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetaminophen, nimodipine in postictal delirium, Postictal Headache (PIH), sponsored by Rijnstate. Started Dec 2019; status: completed.
02
Drugs
acetaminophennimodipine
03
Conditions
postictal deliriumPostictal Headache (PIH)
Beyond the preview
Go deeper on NCT04028596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028596.